
Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).
Publication
, Journal Article
Nunez, DJ; D'Alessio, D
Published in: Diabetes Obes Metab
February 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Diabetes Obes Metab
DOI
EISSN
1463-1326
Publication Date
February 2018
Volume
20
Issue
2
Start / End Page
233 / 237
Location
England
Related Subject Headings
- Signal Transduction
- Receptors, Glucagon
- Molecular Targeted Therapy
- Hypoglycemic Agents
- Humans
- Glucagon-Like Peptide-1 Receptor Agonists
- Glucagon-Like Peptide-1 Receptor
- Endocrinology & Metabolism
- Drugs, Investigational
- Diabetes Mellitus, Type 2
Citation
APA
Chicago
ICMJE
MLA
NLM
Nunez, D. J., & D’Alessio, D. (2018). Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors). Diabetes Obes Metab, 20(2), 233–237. https://doi.org/10.1111/dom.13102
Nunez, Derek J., and David D’Alessio. “Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).” Diabetes Obes Metab 20, no. 2 (February 2018): 233–37. https://doi.org/10.1111/dom.13102.
Nunez DJ, D’Alessio D. Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors). Diabetes Obes Metab. 2018 Feb;20(2):233–7.
Nunez, Derek J., and David D’Alessio. “Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors).” Diabetes Obes Metab, vol. 20, no. 2, Feb. 2018, pp. 233–37. Pubmed, doi:10.1111/dom.13102.
Nunez DJ, D’Alessio D. Glucagon receptor as a drug target: A witches' brew of eye of newt (peptides) and toe of frog (receptors). Diabetes Obes Metab. 2018 Feb;20(2):233–237.

Published In
Diabetes Obes Metab
DOI
EISSN
1463-1326
Publication Date
February 2018
Volume
20
Issue
2
Start / End Page
233 / 237
Location
England
Related Subject Headings
- Signal Transduction
- Receptors, Glucagon
- Molecular Targeted Therapy
- Hypoglycemic Agents
- Humans
- Glucagon-Like Peptide-1 Receptor Agonists
- Glucagon-Like Peptide-1 Receptor
- Endocrinology & Metabolism
- Drugs, Investigational
- Diabetes Mellitus, Type 2